Legend Biotech Corporatio... (LEGN)
undefined
undefined%
At close: undefined

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -518.25M -445.72M -386.21M -307.62M -130.37M -1.62M 9.37M
Depreciation & Amortization 20.45M 18.39M 13.92M 9.93M 5.26M 1.68M 217.00K
Stock-Based Compensation 47.68M 34.34M 20.16M 4.76M 1.27M 704.00K -
Other Working Capital 53.04M 118.75M 114.42M 26.07M 54.27M 108.99M 207.40M
Other Non-Cash Items 128.19M 6.65M 187.74M 84.62M -4.36M -6.13M 228.87M
Deferred Income Tax - - -174.94M 9.22M -7.35M -5.66M -
Change in Working Capital -71.34M 186.32M 140.87M -23.92M 52.48M 318.71M -16.50M
Operating Cash Flow -393.28M -200.03M -198.47M -223.00M -83.06M 307.68M -2.38M
Capital Expenditures -22.72M -22.27M -47.11M -49.78M -39.17M -21.02M -887.00K
Acquisitions - - 3.21M 4.03M -460.00K 20.00K 60.00K
Purchase of Investments -4.86B -654.97M -377.96M -72.68M -390.40M -6.00M -
Sales Maturities Of Investments 5.07B 613.61M 230.08M 98.29M 320.85M - -
Other Investing Acitivies -91.70M -14.71M -3.20M -4.03M 50.52M -75.23M 55.00K
Investing Cash Flow 92.79M -78.34M -194.98M -24.17M -58.65M -102.26M -827.00K
Debt Repayment -3.75M -2.60M -1.42M -2.60M -5.06M -219.00K -32.00K
Common Stock Repurchased - - - - - - -
Dividend Paid - - - - - - -
Other Financial Acitivies 211.56M 2.93M 4.64M 159.40M 19.72M 2.72M 3.35M
Financial Cash Flow 791.49M 377.98M 626.66M 618.88M 14.67M 2.50M 3.32M
Net Cash Flow 491.68M 97.09M 233.25M 372.32M -126.80M 208.05M 128.00K
Free Cash Flow -416.00M -222.30M -245.58M -272.78M -122.23M 286.66M -3.26M